Viewing nowZartan Tablet (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

MFDS item code 200604282 · Notified 2006.05.09 · Insurance code 653802260
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
This medication is used to treat hypertension. It also helps to delay the progression of kidney disease in patients with type 2 diabetes and hypertension. Therefore, it is expected to provide both blood pressure control and kidney protection. It is an effective treatment option for improving the patient's condition.
This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses, or the dose may be increased to up to 100 mg once daily if necessary. 3) If blood pressure is not controlled with this drug alone, it may be administered in combination with another antihypertensive drug (e.g., a low-dose diuretic). An additive effect has been observed when administered in combination with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this drug once daily. The dose may be increased to up to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients 75 years of age or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this drug once daily is recommended. 3) Patients with reduced effective intravascular volume For patients who may have reduced effective intravascular volume (e.g., patients being treated with diuretics), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents 6 years of age and older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents 6 years of age and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This drug can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should not be used by women who are pregnant or may become pregnant. This medication should not be administered to patients with severely impaired liver function or patients with genetic lactose intolerance. Caution is required for elderly patients or those with kidney function issues, as well as for patients with excessively low blood pressure or decreased blood volume. Blood pressure, kidney function, and potassium levels in the blood should be routinely monitored during treatment, as electrolyte imbalances, such as hyperkalemia, can occur. If symptoms such as dizziness, severe fatigue, edema, or respiratory distress occur during treatment, consult a physician immediately. This medication lowers blood pressure, so it is recommended to discontinue use within 24 hours prior to surgery. Taking this drug with other antihypertensive medications, potassium-sparing diuretics, or potassium supplements can dangerously increase potassium levels, so consultation with a physician is essential. Furthermore, taking this medication in conjunction with non-steroidal anti-inflammatory drugs (NSAIDs) may reduce blood pressure control and worsen kidney function, so caution is advised. Women who are pregnant or breastfeeding should not take this medication, and breastfeeding should be discontinued or this medication should be replaced with another if breastfeeding. This drug has not been confirmed as safe for children, especially those under 6 years old, and should not be given to children with severely impaired kidney function. In the case of overdose, hypotension and cardiac arrhythmias may occur, and immediate medical attention is required. It is advisable to avoid grapefruit juice while taking this medication, and to store it out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is advisable to keep it in a dry place at a temperature between 15 and 30 degrees.
White oval film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.